Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 18 Terminated 13 Completed 13 Recruiting 9 Unknown 4 Withdrawn 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Gynecologic 3 Thoracic 1 Other solid neoplasm 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Gemcitabine 13 Radiotherapy 12 Androgen Antagonists 12 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Nivolumab 8 toripalimab 7 darolutamide 7 Drug Therapy 7 Radiosurgery 6 Docetaxel 6 Cystectomy 6 enzalutamide 5 apalutamide 5 Mitomycin 5 Cisplatin 5 Axitinib 5 Abiraterone Acetate 5 disitamab vedotin 4 cabozantinib 4 abiraterone 4 Pluvicto 4 Cyclophosphamide 4 tislelizumab 3 lenvatinib 3 fludarabine 3 cemiplimab 3 Sunitinib 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × olaparib × Genitourinary × Clear all

NCT07090369 2025-07-29

LumOnate

Peter MacCallum Cancer Centre, Australia

Phase 1 Not yet recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡